Home
About
Overview
Sharing Data
ORCID
Help
History (75)
Black Lives Matter Worldwide: Retooling Precision Oncology for True Equity of Cancer Care.
Phthirus
Genetic analysis of human H2N2 and early H3N2 influenza viruses, 1957-1972: evidence for genetic divergence and multiple reassortment events.
Pheromones, Human
Balancing the risks and benefits of biologic therapy in inflammatory bowel diseases.
See All 75 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Balancing the risks and benefits of biologic therapy in inflammatory bowel diseases.
Balancing the risks and benefits of biologic therapy in inflammatory bowel diseases. Expert Opin Drug Saf. 2015; 14(12):1915-34.
View in:
PubMed
subject areas
Biological Therapy
Drug Monitoring
Gastrointestinal Agents
Humans
Inflammatory Bowel Diseases
Intestinal Mucosa
Lymphocytes
Randomized Controlled Trials as Topic
Tumor Necrosis Factor-alpha
authors with profiles
Stephen B. Hanauer